Abstract # 2525 An Australasian Leukaemia Lymphoma Group- Trans Tasman Radiation Oncology Group Prospective Multicentre Study Of Limited Chemotherapy And Involved Field Radiotherapy (IFRT) For Clinical Stage I-II Hodgkin Lymphoma (HL)

Presenter: Wirth, Andrew

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

A. Wirth*1, A. Grigg*2, M. Wolf*1, S. Davis*3, M. Hertzberg*4, D. Joseph*5, C. Johnston*6, J. Reynolds*1. , 1Peter MacCallum Cancer Centre, East Melbourne, Australia, 2Royal Melbourne Hospital, Melbourne, Australia, 3Alfred Hospital, Melbourne, Australia, 4Westmead Hospital, Sydney, Australia, 5Sir Charles Gairdner Hospital, Perth, Australia, 6Wellington Hospital, Wellington, New Zealand,

Author Disclosure:
A. Wirth, Amgen Australia, B. Research Grant; A. Grigg, None; M. Wolf, None; S. Davis, None; M. Hertzberg, None; D. Joseph, None; C. Johnston, None; J. Reynolds, None.

E-mail a friend about this abstract:
Enter email address:   

Abstracts Main Page | Logout